# PDRadiopharma

Source: https://nuclide.cc/companies/pdradiopharma/  
Nuclide record `pdradiopharma` (Company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

The Japanese radiopharmaceutical business that PeptiDream bought from FUJIFILM: it sells most of Japan's radioactive diagnostics and the therapies that go with them.

## Summary

PDRadiopharma is a wholly owned subsidiary of PeptiDream, listed on its own company outline as "PeptiDream Inc. 100%". The legal entity started business on 28 March 2022, when the radiopharmaceutical business of FUJIFILM Toyama Chemical transferred to it, but the operation traces back to 1968 - which is why PDRadiopharma holds Japanese approvals granted long before the company existed.

PeptiDream states the subsidiary commercialises 24 diagnostic and 8 therapeutic products in Japan. Its product pages list sodium pertechnetate generators, iodine-123 brain perfusion agents and sodium iodide I-131 therapy capsules; the PMDA's English approval list adds Lutathera and LysaKare (June 2021, originally approved to FUJIFILM Toyama Chemical), Amyvid, MyoMIBG-I123, Tauvid (December 2024) and Raiatt MIBG-I 131 (September 2025). That makes it the counterpart in Japan to Curium or Lantheus in the West: the domestic supplier of the routine agents on which the therapy business rests.

## Fields

- Kind: Company
- Last checked: 2026-09-22
- Also known as: PDRadiopharma Inc.; PDR
- HQ: Tokyo, Japan
- Type: radiopharma
- Website: https://www.pdradiopharma.com/en/

## Sources

- Company outline (shareholder PeptiDream Inc. 100%, business start 28 March 2022): https://www.pdradiopharma.com/en/about/outline/
- PeptiDream company profile (radiopharmaceutical business through PDRadiopharma): https://www.peptidream.com/en/company/profile/
- Diagnostic product list: https://www.pdradiopharma.com/en/hcw/products/diagnostic/
- Therapeutic product list: https://www.pdradiopharma.com/en/hcw/products/therapeutic/

## Connected records

- drugs: [Florbetapir F-18](https://nuclide.cc/drugs/f-18-florbetapir/), [Flortaucipir F-18](https://nuclide.cc/drugs/f-18-flortaucipir/), [Iobenguane I-123 (cardiac use)](https://nuclide.cc/drugs/i-123-mibg-cardiac/), [Lutetium-177 dotatate](https://nuclide.cc/drugs/lutathera/), [Radioactive iodine (I-131)](https://nuclide.cc/drugs/radioactive-iodine/)
- institutions: [Japanese Society of Nuclear Medicine](https://nuclide.cc/institutions/jsnm/), [Pharmaceuticals and Medical Devices Agency](https://nuclide.cc/institutions/pmda/)
- isotopes: [Iodine-123](https://nuclide.cc/isotopes/i-123/), [Iodine-131](https://nuclide.cc/isotopes/i-131/)

---
JSON: https://nuclide.cc/api/v1/entities/pdradiopharma.json